1. Home
  2. LUNG vs AMBI Comparison

LUNG vs AMBI Comparison

Compare LUNG & AMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • AMBI
  • Stock Information
  • Founded
  • LUNG 1995
  • AMBI 1995
  • Country
  • LUNG United States
  • AMBI Brazil
  • Employees
  • LUNG N/A
  • AMBI N/A
  • Industry
  • LUNG Industrial Specialties
  • AMBI Environmental Services
  • Sector
  • LUNG Health Care
  • AMBI Industrials
  • Exchange
  • LUNG Nasdaq
  • AMBI Nasdaq
  • Market Cap
  • LUNG 248.0M
  • AMBI 255.0M
  • IPO Year
  • LUNG 2020
  • AMBI N/A
  • Fundamental
  • Price
  • LUNG $7.30
  • AMBI $5.37
  • Analyst Decision
  • LUNG Strong Buy
  • AMBI
  • Analyst Count
  • LUNG 7
  • AMBI 0
  • Target Price
  • LUNG $13.71
  • AMBI N/A
  • AVG Volume (30 Days)
  • LUNG 237.6K
  • AMBI 6.0K
  • Earning Date
  • LUNG 10-28-2024
  • AMBI 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • AMBI N/A
  • EPS Growth
  • LUNG N/A
  • AMBI 3161.09
  • EPS
  • LUNG N/A
  • AMBI 0.56
  • Revenue
  • LUNG $76,583,000.00
  • AMBI $504,573,816.00
  • Revenue This Year
  • LUNG $22.73
  • AMBI N/A
  • Revenue Next Year
  • LUNG $19.02
  • AMBI N/A
  • P/E Ratio
  • LUNG N/A
  • AMBI $9.86
  • Revenue Growth
  • LUNG 26.26
  • AMBI 25.13
  • 52 Week Low
  • LUNG $5.46
  • AMBI $3.07
  • 52 Week High
  • LUNG $14.84
  • AMBI $8.44
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.60
  • AMBI 61.12
  • Support Level
  • LUNG $7.18
  • AMBI $4.45
  • Resistance Level
  • LUNG $8.59
  • AMBI $6.02
  • Average True Range (ATR)
  • LUNG 0.40
  • AMBI 0.36
  • MACD
  • LUNG -0.16
  • AMBI 0.15
  • Stochastic Oscillator
  • LUNG 7.74
  • AMBI 74.11

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About AMBI Ambipar Emergency Response

Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.

Share on Social Networks: